The Real World, In Practice: How COVID-19 is changing cancer care, health policy and research—for good. Listen Now.
Cancer is smart.
Together, we can
be smarter.
Accelerating cancer research and improving the quality of care requires the entire industry to work together. Our products connect community oncologists, academics, hospitals, life science researchers and regulators on a shared technology platform.
Together, we can learn from the experience of every patient.
For community oncology
OncoCloudTM is the most comprehensive suite of software and services in community oncology. Using our technology, community clinics are providing better care for patients while remaining efficient, independent and financially successful.
Learn more
For life sciences
With access to billions of data points on millions of cancer patients treated across our network, Flatiron is changing the way life science companies are using real-world data to accelerate research and generate evidence.
Learn more
For academics & hospitals
Flatiron’s enriched data infrastructure helps hospitals and academic centers unlock the promise of their EHR data. Researchers and clinicians now have access to research-grade insights from within and beyond the walls of their institution.
Learn moreDo well by doing good. Join the leading cancer technology company.
Life at Flatiron
The talent and dedication of the people working at Flatiron makes everything we do possible. If you’re passionate about having an impact on cancer research and patient care, we’d love to hear from you.
Open positionsLet us tell you more.
We will email you to start the conversation.
NICE Partners with Flatiron Health to Develop Real-World Evidence Research Methodologies
Collaboration will help NICE expand use of real-world data in service of better outcomes for UK cancer patients.
COVID-19 vs. community oncology: Flatiron’s data provides first damage assessment
Early data compiled by Flatiron Health and made available exclusively to The Cancer Letter make it possible to visualize the severe impact of the COVID-19 pandemic.
Prospective Lung Cancer Clinical Study Launches
The study will pilot the use of a technology-enabled prospective data collection platform to facilitate, streamline and simplify the execution of clinical trials.